Found: 12
Select item for more details and to access through your institution.
Population pharmacokinetic-pharmacodynamic modelling and simulation of neutropenia induced by TP300, a novel topoisomerase I inhibitor.
- Published in:
- Journal of Pharmacy & Pharmacology, 2013, v. 65, n. 8, p. 1168, doi. 10.1111/jphp.12065
- By:
- Publication type:
- Article
Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials?
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1410, doi. 10.1002/cpdd.1044
- By:
- Publication type:
- Article
Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 70, doi. 10.1093/jjco/hyaa169
- By:
- Publication type:
- Article
Antimicrobial stewardship with once-weekly follow-up reduced carbapenem prescriptions in an acute care hospital.
- Published in:
- Canadian Journal of Infection Control / Revue Canadienne de Prévention des Infections, 2017, v. 32, n. 4, p. 206
- By:
- Publication type:
- Article
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2828-6
- By:
- Publication type:
- Article
Asian race and origin have no clinically meaningful effects on polatuzumab vedotin pharmacokinetics in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 3, p. 347, doi. 10.1007/s00280-020-04119-8
- By:
- Publication type:
- Article
Combining 'Bottom-Up' and 'Top-Down' Methods to Assess Ethnic Difference in Clearance: Bitopertin as an Example.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling and Simulation.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 12, p. 1564, doi. 10.1002/jcph.969
- By:
- Publication type:
- Article
Mitigating Bond Deterioration under Cyclic Loading and Water Exposure.
- Published in:
- ACI Structural Journal, 2020, v. 117, n. 6, p. 17, doi. 10.14359/51725885
- By:
- Publication type:
- Article
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma.
- Published in:
- Cancer Science, 2021, v. 112, n. 7, p. 2845, doi. 10.1111/cas.14937
- By:
- Publication type:
- Article
Epstein- Barr virus-associated primary central nervous system cytotoxic T-cell lymphoma.
- Published in:
- Neuropathology, 2013, v. 33, n. 4, p. 436, doi. 10.1111/neup.12005
- By:
- Publication type:
- Article
Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 536, doi. 10.1186/1471-2407-12-536
- By:
- Publication type:
- Article